The novel anthraquinone compound Kanglexin (KLX) has been investigated for its potential to prevent EndMT in atherosclerosis by targeting the fibroblast growth factor receptor 1 (FGFR1 ...
Currently, over 95% of H2O2 is industrially produced using the anthraquinone oxidation process, which is highly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback